K Number
K082047
Device Name
SECURACATH CATHETER, MODEL SPK01
Date Cleared
2008-09-30

(74 days)

Product Code
Regulation Number
880.5970
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The SecurAcath is a PICC and is indicated for short and long term use in peripheral vessels to access the central venous system. The catheter may be used for blood sampling and/or infusion therapy. The SecurAcath PICC includes means to secure the catheter via a subcutaneous anchor below the insertion site.
Device Description
The SecurAcath is a single use, sterile, flexible PICC catheter with a useful lengths of up to 60 cm. The length of the catheter has markings at 1 cm interval to allow the user to trim the catheter to the required length. The catheter has a built in subcutaneous securement mechanism to stabilize and keep the catheter in place. The catheter has two lumens which are identical in properties and characteristics. The device is compatible with all 0.018" and smaller guidewires. The proximal end of the catheter has the standard radiology PICC configuration plus the activation mechanism of the securement system built into the Y-body.
More Information

Not Found

No
The description focuses on the physical characteristics and function of a PICC catheter and its securement mechanism, with no mention of AI or ML.

No.
The device's intended use is for vascular access and infusion therapy, not to treat or cure a disease or condition.

No

Explanation: The device description and intended use clearly state that the SecurAcath is a PICC (Peripherally Inserted Central Catheter) used for accessing the central venous system, typically for blood sampling and infusion therapy. It is not described as analyzing or interpreting biological signals or images to diagnose a condition.

No

The device description clearly outlines a physical catheter with lumens, securement mechanisms, and compatibility with guidewires, indicating it is a hardware medical device.

Based on the provided information, the SecurAcath device is not an In Vitro Diagnostic (IVD).

Here's why:

  • Intended Use: The intended use is to access the central venous system via peripheral vessels for blood sampling and/or infusion therapy. This is a direct interaction with the patient's circulatory system for therapeutic and diagnostic purposes (blood sampling), but it's not about testing samples outside the body.
  • Device Description: The description details a catheter designed for insertion into blood vessels. This is an invasive medical device used in vivo.
  • Lack of IVD Characteristics: There is no mention of the device being used to test samples of human origin in vitro (outside the body) to provide information about a physiological state, health, or disease.

IVDs are typically devices like test kits, reagents, or instruments used to analyze samples such as blood, urine, or tissue in a laboratory setting. The SecurAcath is a device used within the body for accessing the vascular system.

N/A

Intended Use / Indications for Use

The SecurAcath is a PICC and is indicated for short and long term use in peripheral vessels to access the central venous system. The catheter may be used for blood sampling and/or infusion therapy. The SecurAcath PICC includes means to secure the catheter via a subcutaneous anchor below the insertion site.

Product codes

OKC

Device Description

The SecurAcath is a single use, sterile, flexible PICC catheter with a useful lengths of up to 60 cm. The length of the catheter has markings at 1 cm interval to allow the user to trim the catheter to the required length. The catheter has a built in subcutaneous securement mechanism to stabilize and keep the catheter in place. The catheter has two lumens which are identical in properties and characteristics.

The device is compatible with all 0.018" and smaller guidewires. The proximal end of the catheter has the standard radiology PICC configuration plus the activation mechanism of the securement system built into the Y-body.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

central venous system, peripheral vessels

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

The performance test data is provided in the 510(k) submission. The performance data demonstrates that the device meets all the product specifications. Performance testing included dimensional verification; securement reliability, catheter tensile strength. Test results demonstrate that the device is safe and effective for its intended use.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

K0001901, K060887, K041849, K053501, K943147

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 880.5970 Percutaneous, implanted, long-term intravascular catheter.

(a)
Identification. A percutaneous, implanted, long-term intravascular catheter is a device that consists of a slender tube and any necessary connecting fittings, such as luer hubs, and accessories that facilitate the placement of the device. The device allows for repeated access to the vascular system for long-term use of 30 days or more, and it is intended for administration of fluids, medications, and nutrients; the sampling of blood; and monitoring blood pressure and temperature. The device may be constructed of metal, rubber, plastic, composite materials, or any combination of these materials and may be of single or multiple lumen design.(b)
Classification. Class II (special controls) Guidance Document: “Guidance on Premarket Notification [510(k)] Submission for Short-Term and Long-Term Intravascular Catheters.”

0

K082047

SEP 3 0 2008

510(K) SUMMARY 1.

1.1 ADMINISTRATIVE INFORMATION

1.1.1 Name and address

Sponsor: Interrad Medical, Inc. 181 Cheshire Lane, Suite 100 Plymouth, MN 55441 Tel: 763-225-6699 Fax: 763-225-6695

Contact Person Sew-Wah Tay, PhD Regulatory Consultant 18555 37th Ave N, Plymouth, MN 55446

Tel: 612-801-6782 Fax: 763-208-4465 Email: swtay(@)libramed.com

Date Prepared: July 15 2008

1.1.2 Device Name

Trade NameSecurAcath Catheter
Common NamePeriphery Inserted Central Catheter
(PICC)
Classification NameImplanted subcutaneous securement
catheter
Product CodeOKC
Classification21 CFR 880.5970
Class II
ModelSPK01
1.1.3 Applicant

Applicant's Name: Interrad Mcdical, Inc. 181 Cheshire Lane, Suite 100 Plymouth, MN 55441 Tel: 763-225-6699 Fax: 763-225-6695

1

K082047

1.2 Indication for use

The SecurAcath is a PICC and is indicated for short and long term use in peripheral vessels to access the central venous system. The catheter may be used for blood sampling and/or infusion therapy. The SecurAcath PICC includes means to secure the catheter via a subcutaneous anchor below the insertion site.

1.3 DEVICE DESCRIPTION

The SecurAcath is a single use, sterile, flexible PICC catheter with a useful lengths of up to 60 cm. The length of the catheter has markings at 1 cm interval to allow the user to trim the catheter to the required length. The catheter has a built in subcutaneous securement mechanism to stabilize and keep the catheter in place. The catheter has two lumens which are identical in properties and characteristics.

The device is compatible with all 0.018" and smaller guidewires. The proximal end of the catheter has the standard radiology PICC configuration plus the activation mechanism of the securement system built into the Y-body.

1.4 SUBSTANTIAL EQUIVALENCE

The SccurAcath Catheter device covered by this submission is substantially equivalent to other legally marketed devices namely, the Poly-Per-Q (K0001901) Angio Dynamic Morpheus PICC (K060887), Cook Tubo0Flo (K041849), Bard Power PICC (K053501) and the Statlock CV (K943147).

The SecurAcath™ has the same general indication for use, similar principles of opcration, and similar technological characteristics as the previously cleared predicate devices. The differences between this device and its predicate devices do not raise new questions of safety or efficacy.

1.5 Performance Data

The performance test data is provided in the 510(k) submission. The performance data demonstrates that the device meets all the product specifications. Performance testing included dimensional verification; securement reliability, catheter tensile strength. Test results demonstrate that the device is safe and effective for its intended use.

2

Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized caduceus, which is a symbol of medicine, and the text "DEPARTMENT OF HEALTH & HUMAN SERVICES. USA" arranged in a circular fashion around the symbol. The caduceus is depicted with three curved lines representing the snakes intertwined around a staff, which is a common representation of the symbol.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

SEP 3 0 2008

Interrad Medical, Incorporated C/O Dr. Sew-Wah Tay Regulatory Consultant Libra Medical, LLC 18555 37th Avenue North Plymouth, Minnesota 55446

Re: K082047

Trade/Device Name: SecurAcath 5F Dual Lumen PICC 65cm with Subcutancous Securement System Regulation Number: 21 CFR 880.5970 Regulation Name: Percutaneous, Implanted, Long-Term Intravascular Catheter Regulatory Class: II Product Code: OKC Dated: July 17, 2008 Reccived: July 18, 2008

Dear Dr. Tay:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition. FDA may publish further announcements concerning your device in the Federal Register.

3

Page 2 - Dr. Tay

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits vour device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at 240-276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at 240-276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers. International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours,

Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

4

SECTION 4.

INDICATION FOR USE STATEMENT

510(k) Number (if known): *082047

Device Name: SecurAcath Indications for Use:

The SecurAcath is a PICC and is indicated for short and long term use in peripheral vessels to access the central venous system. The catheter may be used for blood sampling and/or infusion therapy. The SecurAcath PICC includes means to secure the catheter via a subcutaneous anchor below the insertion site.

Prescription Use _____________________________________________________________________________________________________________________________________________________________ Over-The-Counter Use _ X AND/OR (Part 21 CFR 801 Subpart D) (21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Cinton Q. Rose

(Division Sign-Off) Division of Anesthesiology, General Hospital Infection Control, Dental Devices

K482047 510(k) Number: